The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

World Health Organization

View/Open

9789241549899-eng.pdf (‎1.434Mb)‎

View Statistics

Show Statistical Information

Altmetrics

Share

Citation

World Health Organization. (‎2016)‎. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. World Health Organization. http://www.who.int/iris/handle/10665/250614

Description

58 p.

ISBN

9789241549899

Collections

Publications

Language

English

Metadata

Show full item record

Show Statistical Information

The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

View/Open

View Statistics

Altmetrics

Share

Citation

Description

ISBN

Collections

Language

Metadata

Related items

Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens ﻿

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis / Bjorn Blomberg ... [‎et al.]‎ ﻿

WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis ﻿

Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis / Bjorn Blomberg ... [‎et al.]‎

WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis